Checkpoint Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Checkpoint Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2015 to Q3 2024.
  • Checkpoint Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 175M shares, a 119% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 175M +95M +119% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 175M +95M +119% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 80M +30M +60% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 80M +30M +60% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 80M -55M -40.7% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 80M -55M -40.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 50M -85M -63% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 50M +36.5M +270% Dec 31, 2022 10-K 2024-03-22
Q3 2022 135M 0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 135M 0 0% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 135M +40M +42.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 13.5M -81.5M -85.8% Dec 31, 2021 10-K 2023-03-31
Q3 2021 135M +40M +42.1% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 135M +40M +42.1% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 95M +35M +58.3% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 95M 0 0% Dec 31, 2020 10-K 2022-03-28
Q3 2020 95M +35M +58.3% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 95M +35M +58.3% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 60M 0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 95M +35M +58.3% Dec 31, 2019 10-Q 2020-08-06
Q3 2019 60M 0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 60M 0 0% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 60M +10M +20% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 60M 0 0% Dec 31, 2018 10-K 2020-03-11
Q3 2018 60M +10M +20% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 60M +10M +20% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 50M 0 0% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 60M +10M +20% Dec 31, 2017 10-Q 2018-11-02
Q3 2017 50M 0 0% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 50M Jun 30, 2017 10-Q 2017-08-09
Q1 2017 50M Mar 31, 2017 10-Q 2017-05-10
Q4 2016 50M 0 0% Dec 31, 2016 10-K 2018-03-16
Q3 2016 50M Sep 30, 2016 10-Q 2016-11-14
Q4 2015 50M Dec 31, 2015 10-K/A 2017-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.